enzymes (such as alkaline phosphatase and 5 ′ -nucleotidase), and complement regulatory proteins (CD55 and CD59), playing roles in cell-cell and cell-environment interactions (13) (14) (15) . GPI, consisting of phosphatidylinositol (PI), glucosamine (GlcN), three mannoses (Man), and three ethanolamine phosphates, is synthesized from PI in the ER, and preassembled GPI is transferred to the protein's carboxyl terminus (14) (15) (16) . In mammalian cells, the majority of protein-linked GPI contains 1-alkyl-2-acyl PI, whereas most free PIs from which GPIs are generated are in the diacyl form. The fi rst and second intermediates of GPI precursors, N -acetyl glucosaminyl (GlcNAc)-PI and GlcN-PI, are mostly diacyl forms, whereas about 60% of the third intermediate, GlcN-(inositol-acylated)-PI (GlcN-acyl-PI), contain 1-alkyl-2-acyl PI, indicating that the 1-alkyl chain is generated after the third biosynthetic step in the ER ( 17 ) . We reported that generation of the 1-alkyl-2-acyl form of GPI is dependent upon the peroxisomal alkyl-phospholipid biosynthetic pathway ( 18 ) : Two different Chinese hamster ovary (CHO) mutant cell lines, NRel-4 and NZel-1 cells, which were defective in DHAP-AT or alkyl-DHAP synthase, respectively ( 19, 20 ) , did not produce a detectable amount of the 1-alkyl-2-acyl form of GPI ( 18 ) . It is conceivable that a putative alkyl-containing lipid donor is generated in the ER from alkyl-DHAP and is used in the remodeling reaction that converts the diacyl form GlcN-acyl-PI to the 1-alkyl-2-acyl form ( Fig. 1 ) .
These results suggested that remodeling of the diacyl form of GPI to the 1-alkyl-2-acyl form would not occur in cells from patients with RCDP types 2 and 3. Cells from
In rhizomelic chondrodysplasia punctata (RCDP) type 1, which is characterized by lethality between 2-3 years of age, a typical facial appearance, cataracts, skeletal dysplasia, microcephaly, and severe psychomotor defects, biosynthesis of alkyl-phospholipids and plasmalogens, and degradation of phytanic acid derived from phytol in chlorophyl are defective, whereas peroxisome membrane biogenesis per se and incorporation of PTS1-bearing proteins are not severely affected. RCDP type 1 is caused by mutation in PEX7 that is essential for transferring the minor group of enzymes bearing a PTS2, such as 3-ketoacyl-CoA thiolase of fatty-acid ␤ -oxidation pathway, alkyl-dihydroxyacetone phosphate synthase (alkyl-DHAP synthase), which is required for synthesis of alkyl-phospholipids, and phytanoyl-CoA 2-hydroxylase, which is required for degradation of phytanic acid ( 3 ) . Specifi c defects in DHAPacyltransferase (DHAP-AT) and alkyl-DHAP synthase (also called alkylglycerone phosphate synthase), the fi rst two enzymes in the alkyl-phospholipid biosynthetic pathway, cause disorders similar to RCDP type 1, termed RCDP type 2 and type 3, respectively (10) (11) (12) , indicating that the major symptoms of RCDP are due to defective biosynthesis of plasmalogens and/or other alkyl-phospholipids, such as platelet activating factor.
More than 150 different cell surface proteins in mammalian cells are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). GPI-anchored proteins (GPI-APs) include receptors (such as folate receptor and urokinase-type plasminogen activator receptor), adhesion molecules (such as neural cell adhesion molecule), Fig. 1 . Peroxisome-dependent lipid remodeling of GPI and biosynthesis of plasmalogens. Plasmalogens are synthesized from DHAP through multiple reaction steps. The fi rst two steps, mediated by DHAP-AT and alkyl-DHAP synthase, occur in the peroxisome; further reactions occur in the ER. Lipid remodeling of GPI, namely conversion of diacyl GPI into 1-alkyl-2-acyl GPI, occurs in the ER, requiring a putative alkyl donor lipid that is derived from 1-alkyl-DHAP. Import of DHAP-AT and alkyl-DHAP synthase into the peroxisome is dependent upon PEX5 and PEX7, respectively. Incorporation of membrane proteins into the peroxisomal membrane is dependent upon PEX3, PEX16, and PEX19. Defi ciencies of PEX3, PEX5, PEX16, or PEX19 cause ZS, whereas those of PEX7, DHAP-AT, and alkyl-DHAP synthase cause RCDP types 1, 2, and 3, respectively.
by guest, on January 5, 2018 www.jlr.org Downloaded from ZPG207/FLAG-ClPEX7, and ZP139 complemented with HAtagged hamster Pex5L , termed 139/5L-HA, were kind gifts from Drs. Yasuhiro Miyauchi and Kanji Okumoto, Kyushu University, respectively. For mass analysis of GPI, we generated ZPG207 cells stably expressing His-FLAG-GST-FLAG-tagged CD59 (HFGF-CD59). The CHO mutant cells NRel-4 and NZel-1 defective in DHAP-AT and alkyl-DHAP synthase, respectively, are gifts from R. A. Zoeller (Boston University, MA) ( 19, 20 ) . pcDNA3.1/Zeo(+)-DHAP-AT plasmid was electroporated into NRel-4 and NZel-1 cells under the conditions of 1000 F/260V. After 3 days, the cells were stained by mouse IgG1 monoclonal antibody clone 5D6 against hamster uPAR ( 40 ) and phycoerythrin-conjugated goat anti-mouse IgG (BD Biosciences, Franklin Lakes, NJ), and analyzed by FACS Calibur (BD Biosciences). In Western blotting, antibodies for Calnexin and Caveolin-1 (BD Biosciences), ␣ -Tubulin (Sigma-Aldrich, St. Louis, MO), and glyceraldehydephosphate dehydrogenase (GAPDH, Life Technologies, Carlsbad, CA) were used.
Mass spectrometric analysis of PI from GPI-AP and HFGF-CD59
We used approximately 1 nmol (50 g) of HFGF-CD59 for mass analysis of the PI moiety. The PI portion was isolated from affi nitypurifi ed HFGF-CD59 by deamination with sodium nitrite as described previously ( 18 ) . PI derived from HFGF-CD59 was stored at -80°C until MS analysis. In CHO cells, data are cited from reference 18, and the method was described in same reference. For analysis of PI in ZPG207 cells, Nano ESI-MS/MS analysis was performed in negative ion mode using a 4000Q TRAP (AB Sciex, Foster City, CA) with a chip-based ionization source, TriVersa NanoMate (Advion BioSystems, Ithaca, NY). The ion spray voltage was set at -1.2 kV, the gas pressure at 0.3 psi, and the fl ow rate at 200 nl/min. The parameter settings were m/z 400-1,200 for scan range, -100 V for declustering potential, -50 to -60 volts for collision energy, and Q1/Q3 "unit" resolution. Samples were dissolved in C/M (1:2) containing 5 mM ammonium formate for injection into the mass spectrometer. The molecular species of PI that were liberated from HFGF-CD59 were directly subjected to fl ow injection and selectively analyzed by precursor ion scanning of the phosphoryl inositol part ( 59 ) . The structure of each PI molecular species was confi rmed by MS/MS analysis of the precursor ion.
In vivo labeling of cells with 3 H-mannose and a test for the alkali resistance of GPI Before labeling, cells (3 × 10 6 in a 60-mm dish) were cultured in medium containing 10 M BE49385A/YW3548, a PIG-N patients with RCDP type 1 might also be defective in this remodeling. It is also likely that cells from patients with ZS are defective in generating 1-alkyl-2-acyl GPI. In this study, we investigated these hypotheses using CHO cells defective in PEX7, PEX5, or PEX19 and fi broblasts from patients with RCDP types 1, 2, or 3, or ZS (21) (22) (23) 
MATERIALS AND METHODS

Cells and materials
Fibroblast cell lines defective in PEX7, termed Gifu R01 and R03, were derived from two patients with RCDP type 1; those defective in PEX5, termed 2-07, and those defective in PEX16, termed D-01, were from patients with ZS; those defective in DHAP-AT, termed NL-#2 and #3, and those defective in alkyl-DHAP synthase, termed NL-#5 and #6, were from patients with RCDP type 2 and patients with RCDP type 3, respectively ( 24, 54 ) . This study was approved by internal review committees in the Research Institute for Microbial Diseases of Osaka University, Gifu University School of Medicine, and University of Amsterdam. Written informed consent for specifi c research use was not obtained because all patients died within a few years after birth. The research use of their fi broblast cells that were taken for diagnostic purposes and stored frozen was approved by the internal review committees because these are rare lethal diseases for which investigation of the disease mechanism is important for the wellness of patients with ZS and RCDP and their families. To generate immortalized cell lines, we introduced cDNAs of human telomerase reverse transcriptase and SV40-T into fi broblast cell lines using a retrovirus vector (55) (56) (57) (58) . The immortalized cells were cultured in MEM medium with 10% FBS supplemented with 100 g/ml of G418 and 0.5 g/ml of puromycin to maintain plasmids. To complement RCDP fi broblasts, human PEX7 and DHAP-AT cDNAs were transduced using a retrovirus vector with a blasticidin resistance gene, and the cells were maintained in 10 g/ml of blasticidin (InvivoGen, San Diego, CA). The PEX mutant and complemented CHO cells have been reported previously ( 21, 22, 34 ) . ZPG207, ZP139, and ZP119 are defective in PEX7, PEX5, and PEX19, respectively. We used ZPG207 complemented with human PEX7 cDNA, termed ZPG207P7 ( 22 ) , and ZP119 complemented with human PEX19 , termed 119/P19 ( 34 ) . ZPG207 complemented with FLAG-tagged hamster Pex7 , termed Fig. 2 . Transfection of human PEX7 restored the localization of PTS2-bearing protein at the peroxisome in PEX7-defective CHO cells. PTS2-GFP is diffuse in PEX7-defective ZPG207 cells (top panels), whereas a punctate distribution of PTS2-GFP was restored by transfection with human PEX7 (bottom panels). Cells were observed for GFP (left-hand panels) and stained with anti-catalase antibody (middle panels). Merged profi les are shown in the right-hand panels. Scale bars, 20 m. by human PEX7 cDNA was confi rmed by the punctate pattern of PTS2-GFP staining that coincided with the staining pattern of catalase, an endogenous peroxisome enzyme ( Fig. 2 ) . We then analyzed production of the 1-alkyl-2-acyl form of GPI by testing alkali sensitivity ( Fig. 3A ) . Due to the sensitivity of ester linkage to KOH treatment, diacyl form GPI is lost from the organic phase, whereas 1-alkyl-2-lyso GPI generated from 1-alkyl-2-acyl from GPI remained in the organic phase and can be detected by TLC analysis. In ZPG207 cells, all spots of GPI biosynthetic intermediates labeled with mannose disappeared after KOH treatment ( Fig. 3B , lane 4) , and expression of PEX7 restored the alkali-resistant 1-alkyl-2-lyso forms of GPI intermediates (Fig. 3B, lanes 7 and 8) . To determine the structure of the PI moiety of protein-linked GPI, we generated ZPG207 cells stably expressing CD59, a human GPI-anchored protein, bearing tandem His-, FLAG-, glutathione S -transferase (GST)-, and FLAG-tags at the N-terminus (HFGF-CD59). We affi nity-purifi ed HFGF-CD59 with glutathione-Sepharose and released the PI moiety from approximately 1 nmol of protein by treatment with sodium nitrite ( 28, 29 ) and subjected it to nano ESI-MS analysis ( Fig. 3C ). All PIs in HF-GF-CD59 from ZPG207 cells were the diacyl form ( (Fig. 3C, right top) . In contrast, wild-type CHO-K1 cells contained mostly 1-alkyl-2-acyl PI ( Fig. 3C , left top) ( 18 ) . Therefore, PEX7 is required for the production of the 1-alkyl-2-acyl form of GPI anchors.
We next analyzed fi broblast cell lines previously established from patients with RCDP type 1. As in CHO cells, signifi cant fractions of GPI intermediates in wild-type fibroblasts were resistant to alkali, indicating generation of 1-alkyl-2-acyl GPI ( Fig. 3D , lanes 1 and 4) . Alkali-resistant GPI was greatly decreased in patients' cells (Fig. 3D , lanes 5 and 6). After complementation with human PEX7 cDNA, the alkali-resistant GPIs were generated at levels comparable to those in wild-type cells (Fig. 3D, lanes 9 and 10) , establishing that generation of 1-alkyl-2-acyl GPI anchors is defective in RCDP type 1.
inhibitor (a gift from Banyu Pharmaceutical) for 12-16 h ( 60, 61 ). When PIG-N, which transfers ethanolamine-phosphate sidebranch to the fi rst Man, is inhibited, Man-containing GPI intermediates lacking the side-branch are accumulated, and effi cient radio-labeling is achieved ( 60 ) . Cells were then incubated in 2.5 ml of glucose-free RPMI-1640 medium (Gibco/Invitrogen) containing 10 g/ml tunicamycin (Wako Pure Chemical Industries, Ltd.), 10% dialyzed FBS, 20 mM HEPES, and 100 g/ml D-glucose for 1 h. After tunicamycin treatment, 40 Ci/ml for CHO cells or 10 Ci/ml for fi broblasts of D- [2- 3 H(N)]mannose (American Radiolabeled Chemicals) was added, and incubation was continued for 1 h. Lipids were extracted from the cell pellet using two 300-l aliquots of water-saturated butanol (BuOH). The extracted lipids were treated with 500 l of 0.1 N KOH in methanol (MeOH) or MeOH only for 1 h at 37°C. To neutralize the solutions, 50 l of 1 M acetic acid or water was added, and the samples were evaporated to dryness using a speed-vac. The lipids were extracted using two 300-l aliquots of water-saturated BuOH and back-washed with 200 l of BuOH-saturated water. After evaporation, the extracted lipids were used as samples for TLC on activated high-performance TLC silica gel 60 plates (Merck) with a developing solvent system of chloroform/MeOH/H 2 O (10:10:3).
Immunofl uorescence microscopy
Cells were washed with PBS, fi xed with PBS containing 4% paraformaldehyde for 20 min at room temperature, and permeabilized with PBS containing 1% BSA, 0.1% NaN 3 , and 0.1% Triton X-100. Cells were stained with combinations of rabbit antihuman catalase serum (1:3,000) and Alexa 594-conjugated goat secondary antibodies. For uPAR staining, cells were permeabilized with PBS containing 0.1% saponin instead of Triton X-100 and stained with 5 g/ml anti-uPAR mAb (clone 5D6) and Alexa 488-conjugated goat secondary antibodies (Invitrogen). Images were acquired on a FluoView FV1000 (Olympus).
RESULTS
GPI lipid remodeling to generate 1-alkyl-2-acyl GPI is defective in PEX7 mutant CHO cells and fi broblasts from patients with RCDP type 1 PEX7 is required for transporting proteins bearing a PTS2, such as alkyl-DHAP synthase, into the peroxisome and is a causal gene for RCDP type 1 (24) (25) (26) (27) . We tested whether a defect in PEX7 affects the lipid remodeling of GPI. We fi rst tested the PEX7 -mutant CHO cell line ZPG207 and ZPG207 transfected with human PEX7 cDNA ( 22 ) . Normalization of the PTS2-bearing protein distribution Cells were metabolically labeled with D- [2- 3 H] mannose in the presence of BE49385A to accumulate late GPI intermediates. The extracted lipids were treated with 0.1 N KOH in MeOH or with MeOH alone and analyzed by TLC. H3-H7', mannose-containing GPI intermediates; H3*-H7'*, alkaline-resistant part of H3-H7'. Lanes 1 and 3, wild-type CHO-K1; lanes 2 and 4, ZPG207; lanes 5 and 7, ZPG207 complemented with human PEX7; lanes 6 and 8, ZPG207 complemented with hamster Pex7; lanes 1, 2, 5, and 6, MeOH-treated cells; lanes 3, 4, 7, and 8, KOH-treated cells. C: Mass analysis of PI moieties in HFGF-CD59 from the plasma membrane of wild-type CHO-K1 and PEX7-defective ZPG207 cells. In CHO-K1 cells, 1-alkyl-2-acyl species (16:0e-18:0, 18:1e-18:0, and 18:0e-18:0) were dominant (left top, data cited from reference 18 ), whereas only diacyl species were found in ZPG207 cells (left bottom). 
Fibroblasts from patients with RCDP types 2 and 3 are defective in 1-alkyl-2-acyl GPIs
We next assessed generation of alkali-resistant GPI in fibroblast cell lines from patients with RCDP types 2 and 3. As expected from our previous results with mutant CHO cells defective in DHAP-AT and alkyl-DHAP synthase, all spots of GPI-mannolipids generated in these cells from RCDP type 2 and type 3 patients disappeared after alkali treatment ( Fig. 4 , lanes 7-10) . When the responsible DHAP-AT cDNA was transfected into RCDP type 2 fi broblasts, spots of the alkali-resistant lyso-forms appeared (Fig. 4, lanes 13 and  14) . It is, therefore, evident that generation of 1-alkyl-2-acyl GPI-APs is defective in RCDP types 2 and 3.
GPI lipid remodeling to generate 1-alkyl-2-acyl GPI is defective in PEX5-and PEX19-mutant CHO cells and fi broblasts from patients with ZS
PEX5 recognizes the PTS1 signal and imports many proteins bearing a PTS1 into the peroxisome. A defect in PEX5 causes ZS. PEX16 and PEX19 are required for incorporation of peroxisomal membrane proteins into the membrane ( 3, (30) (31) (32) . Defects in PEX16 and PEX19 also cause ZS ( 3, 33 ) . First, we analyzed PEX5-defective CHO cells ( Fig. 5A , lanes 2 and 5) and PEX19-defective CHO cells (Fig. 5A , lanes 3 and 6) ( 21, 34 ). Man-labeled GPIs generated in these mutant CHO cells disappeared after KOH treatment (Fig. 5A , lanes 5 and 6). Expression of PEX5 and PEX19 restored the production of alkali-resistant GPIs (Fig. 5A, lanes 9 and 10) . Next, we tested fi broblast cell lines from patients with ZS ( Fig. 5B ) . Cells from PEX5-defective (Fig. 5B, lanes 2 and 5) and PEX16-defective (Fig. 5B, lanes 3 and 6) patients did not produce alkali-resistant GPIs (Fig. 5B, lanes 3 and 6) . These results indicate that PEX5, PEX16, and PEX19 are required for the generation of 1-alkyl-2-acyl GPI anchors and that patients with ZS are defective in generation of 1-alkyl-2-acyl GPI-APs.
Surface expression of urokinase-type plasminogen activator receptor, a GPI-AP, signifi cantly increase when alkylphospholipid biosynthesis is defective
We next asked if a defect in peroxisome-dependent alkylphospholipid biosynthesis affects any properties of GPI-APs other than lipid remodeling to 1-alkyl-2-acyl form. We focused on urokinase-type plasminogen activator receptor (uPAR), an endogenous GPI-AP of CHO cells. We used NRel-4 and NRel-1 cells defective in DHAP-AT and alkyl-DHAP synthase, respectively ( 19, 20 ) . The surface expression of uPAR on NRel-4 cells was 4-times of that on wild-type CHO-K1 cells and returned to 1.5-times of normal level by transfection of DHAP-AT cDNA ( Fig. 6A ) . Similarly, uPAR on NZel-1 cells was 2-times of that on CHO-K1 cells and returned to 1.4-times of normal level by transfection of alkyl-DHAP synthase cDNA ( Fig. 6A ) . To see if the increased surface expression of uPAR was due to an increase in total cellular uPAR level or to a skew in a ratio of surface to intracellular uPAR fractions, we used confocal fl uorescence microscopy. The total cellular level of uPAR was higher in NRel-4 and NZel-1 cells than in CHO-K1 cells and was substantially decreased after transfection of DHAP-AT and alkyl-DHAP synthase cDNAs, respectively (Fig. 6B) . We assessed the amounts of uPAR and some nonGPI-APs, such as calnexin, ␣ -tubulin, glyceraldehydephosphate dehydrogenase, and caveolin-1, with Western blotting before and after PI-PLC treatment ( Fig. 6C ) . Most of the uPAR was lost by PI-PLC treatment, indicating that most cellular uPAR was on the cell surface (Fig. 6C, top panel, lanes 1-5  vs. lanes 6-10) . Levels of uPAR were clearly higher in removal of the inositol-linked acyl chain from nascent GPIAPs does not occur due to a defect in the inositol-deacylase PGAP1, transport of GPI-APs from the ER to the Golgi apparatus is delayed, and sensitivity to PI-specifi c phospholipase C is lost ( 37 ) . Pgap1 -knockout mice have high rates of perinatal death due to craniofacial deformity (in particular otocephaly), growth retardation, and male infertility ( 38 ) . The mutant mouse strain oto characterized by otocephaly is due to mutation in Pgap1 ( 39 ) . Another example is GPI fatty acid remodeling occurring in the Golgi, in which an unsaturated fatty acid at the sn2 position is exchanged with saturated, stearic acid. When the fatty acid remodeling does not occur due to a defect in PGAP3, which is involved in removal of the sn2-linked unsaturated fatty acid, GPI-APs are present in the detergent-sensitive fraction rather than in the detergent-resistant membrane fraction after extraction with a cold nonionic detergent such as Triton X-100 ( 40 ) . Pgap3 -knockout mice have a number of abnormal phenotypes, including growth retardation and immune dysfunction ( 41 ) . Overall, it is possible that a lack of 1-alkyl-2-acyl GPI-APs accounts for some of the clinical symptoms of ZS and RCDP.
Mammalian cells elaborate 1-alkyl-2-acyl GPI-APs from diacyl PI via at least two events. The fi rst event, which occurs in the third biosynthetic intermediate GlcN-acyl-PI, is replacement of a diacyl glycerol moiety or a diacyl glycerol phosphate moiety ( 17, 18 ) . In CHO cells and mouse Tlymphoma cell lines, approximately 60% of GPIs are converted to the 1-alkyl-2-acyl form at this stage ( 17 ) . Because NRel-4 and NZel-1 cells than in parental CHO cells (Fig.  6C , lanes 2 and 4 vs. lane 1) and were substantially decreased after transfection of cDNAs responsible for the mutants (Fig. 6C, lanes 3 and 5) . In contrast, expression levels of calnexin, ␣ -tubulin, and glyceraldehydephosphate dehydrogenase were not changed with or without alkyl phospholipids synthesis (Fig. 6C , three middle panels). Consistent with a previous report that levels of GPIAPs and caveolin-1 are inversely correlated in CHO cells ( 35 ) , we found that levels of caveolin-1 were decreased in NRel-4 and NZel-1 cells and were increased after transfection of responsible cDNAs (Fig. 6C, bottom panel) . These results suggest that the defective alkylphospholipid synthesis causes increased surface expression of uPAR probably due to slowed turnover. Whether this remarkable phenotype is due to the diacyl form GPI anchor itself, to a lack of alkyl/alkenyl phospholipids such as plasmalogens, or both is yet to be determined.
DISCUSSION
The primary fi nding of this study is that cells from patients with RCDP and ZS are defective in biosynthesis of 1-alkyl-2-acyl GPIs and express only diacyl GPI-APs. Many proteins are anchored by GPI to the cell surface, and the majority of proteins in mammalian cells contain 1-alkyl-2-acyl GPI ( 36 ) . It is known that changes in the fi ne structure of the lipid portion of GPI-APs lead to altered properties of the GPI-APs and various abnormalities. When phosphatase, a GPI-AP that is expressed on the membrane of osteoblasts and that is secreted to the blood during bone formation ( 14, (46) (47) (48) (49) (50) , might be responsible for the abnormal bone formation or chondrodysplasia. Delayed cerebellar development is a hallmark in RCDP and ZS patients, and these patients suffer from severe neonatal neurodegenerative disorders. The severity is related to the importance of peroxisomes in the maturation of the central nervous system. Peroxisomes are abundant at the termini of developing neurons and have been implicated in the early determination of neural polarity ( 51, 52 ) . Although the mechanisms of neuropathology are unknown, ZS leads to loss of essential peroxisomal function and causes problems in cerebellum formation. Neural cell adhesion molecule, a GPI-AP, is expressed on the surface of neural cells and contributes to cell polarization ( 53 ) . The abnormal diacyl form GPI might be causally related to the neurodegenerative phenotypes. Although the functional importance of the alkyl-acyl form of GPI-APs is yet to be determined, our results suggest the possibility that the absence of alkyl-acyl GPI contributes to some of the symptoms of RCDP and ZS.
fatty acid composition of the diacyl form of GlcN-acyl-PI was different from those of earlier GPI intermediates and PI, even the diacyl form must be subjected to replacement reaction ( 18 ) . Therefore, a putative donor lipid for the remodeling presumably comprises 60% of the 1-alkyl-2-acyl form and 40% of the diacyl form ( 18 ) . The exact reaction mechanism of this GPI lipid remodeling is yet to be elucidated. The second event occurs during the following biosynthetic step(s), in which enrichment of the 1-alkyl-2-acyl form proceeds further, leading to occupation of 80-90% of cell surface GPI-APs in CHO cells ( 18 ) . A possible mechanism might be selection by biosynthetic enzymes, selective compartmentalization of the 1-alkyl-2-acyl form, or, although less likely, degradation of diacyl GPI intermediates.
To understand the functional signifi cance of 1-alkyl-2-acyl GPI-APs, the enzyme required for the GPI lipid remodeling needs to be identifi ed and disrupted. If the gene for the putative enzyme that catalyzes diacyl to 1-alkyl-2-acyl exchange in GlcN-acyl-PI is disrupted in mice, such mice would not express 1-alkyl-2-acyl GPI-APs but would have normal plasmalogens; this should allow us to determine the phenotypes that result from defective generation of 1-alkyl-2-acyl GPI-APs. Until this is achieved, information derived from the cells of patients with RCDP types 2 and 3 and CHO mutant cell lines defective in DHAP-AT and alkyl-DHAP synthase is useful. Cells from patients with RCDP types 2 and 3 are defective only in alkyl-phospholipid biosynthesis, resulting in defects in several end-products, namely, plasmalogens, platelet activating factor, and 1-alkyl-2-acyl GPI-APs, whereas cells from patients with RCDP type 1 and ZS are also defective in other peroxisomal pathways. We found that the surface expression of uPAR is 2-to 4-times elevated on mutant cells defective in DHAP-AT or alkyl-DHAP synthase ( Fig. 6 ) . It was reported that these mutant CHO cells are ineffi cient in the transport of cholesterol for the cell surface or endocytic compartment to the ER ( 42 ) . Fibroblasts from patients with RCDP types 2 and 3 display a number of morphological and cell biological abnormalities, such as the common presence of enlarged and multipolar cells, dilated ER and Golgi cisternae, a reduced number of caveolae associated with a 50-60% reduction in caveolin 1, accumulation of cholesterol in perinuclear structures, an increased level of clathrin, and ineffi cient endocytosis of transferrin ( 43 ) . Whether the elevated uPAR expression is related to these cellular abnormalities, including affected cholesterol traffi cking, is unclear.
Dhap-at -knockout mice display a variety of phenotypes, including male infertility, defects in eye development, cataract, optic nerve hypoplasia, and cerebellum anomalies including impaired Purkinje cell innervation, defective myelination, and disturbances in paranode organization ( 44, 45 ) . Patients with RCDP types 2 and 3 have craniofacial dysmorphism, cataract, severe psychomotor retardation, as well as rhizomelia and chondrodysplasia punctata ( 3, (10) (11) (12) . It is tempting to speculate that the lack of a particular 1-alkyl-2-acyl GPI-AP is responsible for some of these abnormalities. For example, abnormal alkaline
